Foundation Venture Capital Group Commits $1 Million to Hackensack Meridian Health’s First Spin-out Company, EValuate Diagnostics
February 08, 2024
The company, based on science from the Hackensack Meridian Center for Discovery and Innovation, promises to capture biomarkers for early detection of disease
EValuate Diagnostics, the first spin-out company from the Hackensack Meridian Health Research Institute and its Office of Innovation and Commercialization, is the newest addition to Foundation Venture Capital Group’s (FVCG’s) portfolio.